Skip to main content

GE Healthcare UK Awarded US Patent

Premium
GE Healthcare UK has been awarded US patent 7,300,762, “Fluorescent proteins and methods of using same.”
 
The inventors listed on the patent are Simon Stubbs, Anne Jones, Nigel Michael, and Nicholas Thomas.
 

The patent provides novel engineered derivatives of green fluorescent protein that have an amino acid sequence that is modified by amino acid substitution compared with the amino acid sequence of wild-type green fluorescent  protein (SEQ ID NO: 2), its abstract said. The modified GFPs exhibit enhanced fluorescence relative to wild-type GFP when expressed in non-homologous cells at temperatures above 30° C, and when excited at about 490 nm. According to the patent abstract, the modified GFPs provide a means for detecting GFP reporters in mammalian cells at lower levels of expression and/or increased sensitivity relative to wild-type GFP. This greatly improves the usefulness of fluorescent proteins in studying cellular functions in living cells, according to the inventors.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.